Cary W. Sucoff
Advisory Board Member
Cary Sucoff has over 30 years of securities industry experience. Mr. Sucoff currently owns and operates Equity Source Partners, LLC an advisory and consulting firm. He has participated in the financing of hundreds of public and private companies.
Mr. Sucoff currently serves on the following Boards of Directors: Contrafect Corp., (CFRX), engaged in the development of new treatments for infectious diseases utilizing proprietary antibody and lysin technology;
Legacy Education Alliance, Inc. (LEAI), provides educational training seminars, conferences, and services in the United States, Canada, the United Kingdom, and internationally;
First Wave Technologies, Inc.; brings to the commercial market new and innovative medical device technologies;
Galimedix Therapeutics, Inc. – pursuing small molecule breakthrough licensed from Tel Aviv University working on potentially revolutionary treatments for Glaucoma and Dry Age-related Macular Degeneration.
In addition, Mr. Sucoff currently serves as a consultant to Sapience Therapeutics, Inc., an early stage Biotech company focusing on Glioblastoma.
Mr. Sucoff, a former New York City prosecutor is the Past President of New England Law/Boston and has been a member of its Board of Trustees for over 25 years. He is Chairman of the Endowment Committee.
Mr. Sucoff received a B.A. from SUNY Binghamton (1974) and a J.D. from New England School of Law (1977) where he was the Managing Editor of the Law Review and graduated Magna Cum Laude. Mr. Sucoff has been a member of the Bar of the State of New York (now retired) since 1978.
Patrick M. Kolenic
Advisory Board Member
Mr. Kolenik has a forty year history working in positions involving all areas of securities trading and management with retail brokerage firms, equities and management of trading desk personnel and investment banking.
Mr. Kolenik is currently the President of Cyndel and Company, an advisory consulting company, and is a General Partner in Huntington Laurel Partners, a hedge fund. Prior to this he held a variety of roles at Sherwood Securities where he progressed to Chairman and CEO. Mr. Kolenik was also the President of WinCapital Corporation, a full service brokerage firm.
He has served as a board member for Sherwood Securities, Paradigm Medical, and WinCapital Corporation in the past and currently serves on the board for SpendSmart Payments Company and Premier Alliance Group.
Advisory Board Member
Mr. Frank is a persuasive and successful lawyer and real estate advisor and developer, with extensive knowledge and experience in both industries. He is the founder of multiple businesses that he also manages and has contributed to the innovation and expansion of their success. With thirty years of experience in law, Ron is known for providing superior service and representing clients in a wide variety of complex disputes by being strategic, efficient, and effective in his proceedings. In both 2004 and 2005, he was selected by the Texas Lawyer as a “Rising Star” and has represented large corporations in the aviation industry such as Delta, Southwest Airlines, and US Airways. Ron is also immersed in real estate, turning distressed properties into immense assets, handling all levels of the project transformation, from financing, design, construction, and leasing, to management and sales. Mr. Frank holds a Doctorate in Jurisprudence from the University of Houston.
Advisory Board Member
Mr. Smithson is a veteran real estate broker and Senior Vice President at NAI San Diego. He was Top Producer in 2008, 2009, 2011, 2012, 2013 and 2015, utilizing his extensive knowledge of the county to specialize in representing industrial land and office tenants throughout the region. Before that, Jason was responsible for sales and marketing of GIS and CRM software solutions, applications, databases, and predictive analytics with ESRI, the largest global Geographic Information Systems provider. Over the last ten years, his focus has primarily been on leasing and tenant representation of local and corporate clients. Some of his valued clients are companies such as Learn4Life (one of the largest charter school concepts in CA.), Modern Times Beer (from their inception), Orora Packaging, Fred Finch Youth Services, and a unique 45,000 square foot outdoor grow facility and lab in Encinitas, CA that is used to produce Jatropha for Biofuel applications. Jason has a master’s degree in international business from Monterey Institute of International Studies and a Bachelor of Arts degree at University of the Pacific. He is also an accomplished and avid golfer, playing on California’s Golden State Tour in 1994 and working for Titleist and Footjoy Worldwide.
BSc, MSc, PhD, MBA
Dr. Bipin Patel is a biotech pharma entrepreneur with over 20 years of experience and a track record for building value across early-stage drug discovery, development, and commercialization. Based in Cambridge, U.K., and highly regarded for his international pharmaceutical business development work, Dr. Patel has established an extensive global big-pharma network across the U.S., Europe, Japan, and China. He specializes in surfacing and shaping opportunities, securing finance, and driving assets to conclusion. He has held senior roles, including CEO, CSO, COO, strategic council, and board of directors. He has driven various initiatives such as drug discovery and preclinical and clinical development in numerous biotech industries. Dr. Patel has a strong business and commercial acumen with an aptitude for deal-making and partnering.
Scientific Advisory Board Member
Mr. Daniel Claycamp is the current Chief Operating Officer for Astra Energy Inc. and past Vice President of Operations for GenCanna Global USA. He is an experienced professional with over 34 years of experience providing executive management for engineering, construction, environmental, and operational activities on several food-grade grain milling, food processing, biofuels, hemp, and cannabis facilities. Dan has also successfully managed greenfield projects in Wisconsin, Illinois, Missouri, and Kentucky from concept design to operational cash flow, with the latest project being an $83M food-grade hemp processing facility. Mr. Claycamp is a graduate of Kansas State University, with a Bachelor of Science degree in Milling Science and Management. He has held senior management positions at top milling companies, including Quaker Oats, Bunge, SEMO Milling, Didion Milling, and United Maize. Dan has successfully managed and directed teams to execute pathways for successful 3rd party accreditations, licenses, permits, and compliance with governing agencies like the FDA, USDA, EPA, ESSA, OSHA, FSMA, SQF, and BRC in the grain milling and food industries. He has also managed and developed supply chain platforms from suppliers to customers that have met and exceeded company visions, goals, and objectives, all focusing on being environmentally friendly and green. Through his 34 years of experience managing several large-scale construction projects, he has gained a deep knowledge of AC and DC electrical design parameters for electrical transformers, switchgear, controls, and motors in either alternating or direct current applications and high, medium, and low voltage design applications. Dan is also a seasoned expert in reviewing and identifying opportunities for process improvements on proposed and current technologies in the food manufacturing and biotechnology industries. As the past Chief Operating Officer of MOR Technology, Dan was crucial in the intellectual property development of fractionation and supercritical extraction technologies and has authored or coauthored 7 United States patents. Mr. Claycamp is currently a board member and director for Greenspot Biomedical located in Peru and is an advisory board member for Green Hygienics Holdings Inc. located in Poway, CA. He has been a member of the Iowa Renewable Fuels Association, Illinois Corn Growers and Marketing Board, International Association of Operative Millers, and Renewable Fuels Association.
Scientific Advisory Board Member
Mr. Mathur currently serves as Scientific Advisor for several premier cannabis and hemp-based operations where he directs efforts on cannabis molecular breeding, designed at the development of pure-line hybrid cultivars with defined chemical profiles tailored for specific therapeutic medical applications. Eric also focuses on high bioavailability drug delivery methods to facilitate medical applications of cannabis products. His expertise and knowledge traverses’ genome sciences, molecular biology, environmental microbiology, plant-microbe interactions, metagenomics, enzyme & drug discovery, plant domestication, and applied biotechnology. Eric’s career spans over 40 years in basic and applied biotechnology with a focus on translational science. He entered the San Diego biotechnology arena early, in 1983, as the founder of Stratagene, where he discovered and commercialized Pfu DNA polymerase, which is still a mainstay enzyme used in the PCR industry. After a nine-year tenure, Mathur was recruited to become the first employee of Diversa Corporation, which later achieved the largest biotech IPO of the time, raising $200MM in 2001. At Diversa, Eric managed a large scientific team and multiple corporate collaborations with industrial partners including Syngenta, Dow Chemical, and BASF. Following 14 years with Diversa, Mathur was recruited to start Craig Venter’s company Synthetic Genomics, where he led research efforts in microbial enhanced hydrocarbon recovery sponsored by BP. He also spearheaded the genome sequencing and annotation of the oil palm genome for Genting Berhad and established a platform for plant growth-promoting bacteria which led to the spinout, Agradis, and subsequent Monsanto acquisition. Eric’s interests then turned to plant genomics and crop domestication. He worked as Chief Scientific Officer for several companies including Yulex Corporation and SG Biofuels, GreenKiss NY and Cultivation Technologies Inc., and more recently Tilt Holdings, where he applied modern genomic tools and plant molecular breeding methods to accelerate plant productivity. His work culminated in dramatic yield improvements in two sustainable crops; Guayule for natural rubber production, and Jatropha for biodiesel. Mathur’s team also made significant advances in cannabis and continues breeding as well as plant improvement activities with a number of organizations. Eric Mathur is an internationally recognized speaker who has authored over 50 peer-reviewed publications and is named Inventor on over 100 issued patents. Eric’s passion lies in leveraging genome-based technologies to develop nutrient-dense foods and therapeutic medicinals. Eric is also an ardent supporter of sustainable agriculture and does his part to help secure global food & energy security while minimizing the impact on our fragile environment.
Chairman – Financial Advisory Board
Ian Subel has been the Managing Director of Fogel Capital Partners since 2011, providing corporate finance advisory services through numerous Family offices and other organizations in, amongst others, insurance, consumer products, healthcare, entertainment technology, energy, oil, and gas sectors. His prior experience includes Chief Financial Officer and Treasurer at LifeFirms Group of Companies, a single-family office where he oversaw the multiple operating entities owned by the Group. Additional experience includes four years at Deloitte Corporate Finance as a Managing Director between 1998 and 2002. He became a Partner during his five-year tenure at Fisher Hoffman Sithole/Panell Kerr Forester. Ian graduated from the University of the Witwatersrand in South Africa with a Bachelor of Commerce and a Bachelor of Accounting; he also holds a CPA and several insurance licenses.
Financial Advisory Board Member
Mr. Piccolo has 15 years of capital raising experience for corporate clients spanning the capital structure. His area of specialization is in the structuring and syndication of private placement products. He has recently advised large public and private companies in the hemp and cannabis sector and has deep relationships within the institutional investing landscape. Dylan is currently Managing Director of Capital Markets in Cowen’s Private Capital Solutions and Debt Capital Markets Groups, which is focused on delivering capital structure advice and private capital solutions for investment banking clients. He was formerly at Stifel, where he served as Director in its Debt Capital Markets group focusing on high yield, senior loans, unitranche, subordinated, second lien, crossing lien, mezzanine, and preferred debt structures. Previously, Mr. Piccolo was an Associate at Oppenheimer & Co., where he began his career providing a full range of wealth management, securities brokerage, and investment banking services. Dylan holds a Bachelor of Business Administration degree from the University of Miami School of Business.
Financial Advisory Board Member
David Mapely has spent 35 years working in the financial markets for major international investment banks in New York, Hong Kong, London, Sydney, Tokyo, Toronto, Switzerland and Luxembourg. He initially managed portfolios of derivatives and bonds but eventually headed up all capital markets trading while based in Japan. He then moved to Hong Kong to head up capital markets sales for Asia, where he and his team advised central banks and big institutional investors on their debt and currency reserves portfolios.
David co-founded the Shimoda Group in 1993, becoming involved in launching investment funds in Vietnam and Far East Russia, and trading Cuba restructured national debt. Shimoda’s activity has since expanded to cover North American, European and Asia-Pacific markets. He was the Chief Investment Officer of the Shimoda Russia Renaissance Fund, the Shimoda Emerging Europe Fund and the Shimoda Alliance Fund. He was also the business manager of Shimoda Resources Holdings listed in the USA. He is/has been an independent director or advisor to several emerging markets investment funds, including the Orion Russia/NIS Opportunity Fund which was the first large Russia/NIS debt fund, launched in 1996. After predicting the Russian debt collapse in 1998, Mapely became active in trading and restructuring emerging European debt including running a debt buy-back program for the National Bank of Romania.
David earned degrees at the London School of Economics, where he also served as a teacher in Probability Theory and Operational Research, before obtaining an MBA at the University of Chicago. He later authored two Euromoney Yearbook chapters on interest-rate/currency swaps, as well as wrote and presented courses on bond portfolio management and bond options. He is a member of the Institute of Directors in London and is also an avid rower.